-
1
-
-
84862505462
-
Differential effect of smoking on long-term outcomes in patients with atherosclerotic vascular disease treated with aspirin or clopidogrel: Insights from the Clopidogrel vs Aspirin in Patients at Risk of Ischemic Events Trial [Abstract]
-
Ferreiro J, Bhatt D, Ueno M. Differential effect of smoking on long-term outcomes in patients with atherosclerotic vascular disease treated with aspirin or clopidogrel: insights from the Clopidogrel vs Aspirin in Patients at Risk of Ischemic Events Trial [Abstract]. J Am Coll Cardiol. 2012;59:A62.
-
(2012)
J Am Coll Cardiol.
, vol.59
-
-
Ferreiro, J.1
Bhatt, D.2
Ueno, M.3
-
2
-
-
0035899289
-
Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation
-
DOI 10.1056/NEJMoa010746
-
Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001;345:494-502. (Pubitemid 32758501)
-
(2001)
New England Journal of Medicine
, vol.345
, Issue.7
, pp. 494-502
-
-
Yusuf, S.1
Zhao, F.2
Mehta, S.R.3
Chrolavicius, S.4
Tognoni, G.5
Fox, K.K.6
-
3
-
-
0038649988
-
Clopidogrel for coronary stenting: Response variability, drug resistance, and the effect of pretreatment platelet reactivity
-
DOI 10.1161/01.CIR.0000072771.11429.83
-
Gurbel PA, Bliden KP, Hiatt BL, O'Connor CM. Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity. Circulation. 2003;107:2908-13. (Pubitemid 36736631)
-
(2003)
Circulation
, vol.107
, Issue.23
, pp. 2908-2913
-
-
Gurbel, P.A.1
Bliden, K.P.2
Hiatt, B.L.3
O'Connor, C.M.4
-
4
-
-
68149180722
-
Recent developments in clopidogrel pharmacology and their relation to clinical outcomes
-
Gurbel PA, Antonino MJ, Tantry US. Recent developments in clopidogrel pharmacology and their relation to clinical outcomes. Expert Opin Drug Metab Toxicol. 2009;5:989-1004.
-
(2009)
Expert Opin Drug Metab Toxicol.
, vol.5
, pp. 989-1004
-
-
Gurbel, P.A.1
Antonino, M.J.2
Tantry, U.S.3
-
5
-
-
8344221349
-
Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction
-
Matetzky S, Shenkman B, Guetta V, Shechter M, Beinart R, Goldenberg I, et al. Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction. Circulation. 2004;109:3171-5.
-
(2004)
Circulation.
, vol.109
, pp. 3171-3175
-
-
Matetzky, S.1
Shenkman, B.2
Guetta, V.3
Shechter, M.4
Beinart, R.5
Goldenberg, I.6
-
6
-
-
27644536235
-
Platelet reactivity in patients and recurrent events post-stenting: Results of the PREPARE POST-STENTING study
-
DOI 10.1016/j.jacc.2005.07.041, PII S0735109705019212
-
Gurbel PA, Bliden KP, Guyer K, Cho PW, Zaman KA, Kreutz RP, et al. Platelet reactivity in patients and recurrent events poststenting: results of the PREPARE POST-STENTING Study. J Am Coll Cardiol. 2005;46:1820-6. (Pubitemid 41579802)
-
(2005)
Journal of the American College of Cardiology
, vol.46
, Issue.10
, pp. 1820-1826
-
-
Gurbel, P.A.1
Bliden, K.P.2
Guyer, K.3
Cho, P.W.4
Zaman, K.A.5
Kreutz, R.P.6
Bassi, A.K.7
Tantry, U.S.8
-
7
-
-
77953911457
-
Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate
-
Bonello L, Tantry US, Marcucci R, Blindt R, Angiolillo DJ, Becker R, et al. Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate. J Am Coll Cardiol. 2010;56:919-33.
-
(2010)
J Am Coll Cardiol.
, vol.56
, pp. 919-933
-
-
Bonello, L.1
Tantry, U.S.2
Marcucci, R.3
Blindt, R.4
Angiolillo, D.J.5
Becker, R.6
-
8
-
-
34250020766
-
Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis
-
DOI 10.1016/j.jacc.2007.01.094, PII S0735109707011345
-
Buonamici P, Marcucci R, Migliorini A, Gensini GF, Santini A, Paniccia R, et al. Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis. J Am Coll Cardiol. 2007;49:2312-7. (Pubitemid 46891710)
-
(2007)
Journal of the American College of Cardiology
, vol.49
, Issue.24
, pp. 2312-2317
-
-
Buonamici, P.1
Marcucci, R.2
Migliorini, A.3
Gensini, G.F.4
Santini, A.5
Paniccia, R.6
Moschi, G.7
Gori, A.M.8
Abbate, R.9
Antoniucci, D.10
-
9
-
-
80052167250
-
Impact of platelet reactivity on clinical outcomes after percutaneous coronary intervention. A collaborative meta-analysis of individual participant data
-
Brar SS, ten Berg J, Marcucci R, Price MJ, Valgimigli M, Kim HS, et al. Impact of platelet reactivity on clinical outcomes after percutaneous coronary intervention. A collaborative meta-analysis of individual participant data. J Am Coll Cardiol. 2011;58:1945-54.
-
(2011)
J Am Coll Cardiol.
, vol.58
, pp. 1945-1954
-
-
Brar, S.S.1
Ten Berg, J.2
Marcucci, R.3
Price, M.J.4
Valgimigli, M.5
Kim, H.S.6
-
10
-
-
48449101872
-
The association of cigarette smoking with enhanced platelet inhibition by clopidogrel
-
Bliden KP, Dichiara J, Lawal L, Singla A, Antonino MJ, Baker BA, et al. The association of cigarette smoking with enhanced platelet inhibition by clopidogrel. J Am Coll Cardiol. 2008;52:531-3.
-
(2008)
J Am Coll Cardiol.
, vol.52
, pp. 531-533
-
-
Bliden, K.P.1
Dichiara, J.2
Lawal, L.3
Singla, A.4
Antonino, M.J.5
Baker, B.A.6
-
11
-
-
70349868299
-
Smoking promotes clopidogrel-mediated platelet inhibition in patients receiving dual antiplatelet therapy
-
Gremmel T, Steiner S, Seidinger D, Koppensteiner R, Panzer S, Kopp CW. Smoking promotes clopidogrel-mediated platelet inhibition in patients receiving dual antiplatelet therapy. Thromb Res. 2009;124:588-91.
-
(2009)
Thromb Res.
, vol.124
, pp. 588-591
-
-
Gremmel, T.1
Steiner, S.2
Seidinger, D.3
Koppensteiner, R.4
Panzer, S.5
Kopp, C.W.6
-
12
-
-
65449170730
-
Predictors of heightened platelet reactivity despite dual-antiplatelet therapy in patients undergoing percutaneous coronary intervention
-
Price MJ, Nayak KR, Barker CM, Kandzari DE, Teirstein PS. Predictors of heightened platelet reactivity despite dual-antiplatelet therapy in patients undergoing percutaneous coronary intervention. Am J Cardiol. 2009;103:1339-43.
-
(2009)
Am J Cardiol.
, vol.103
, pp. 1339-1343
-
-
Price, M.J.1
Nayak, K.R.2
Barker, C.M.3
Kandzari, D.E.4
Teirstein, P.S.5
-
13
-
-
67650901939
-
Factors influencing clopidogrel efficacy in patients with stable coronary artery disease undergoing elective percutaneous coronary intervention: Statin's advantage and the smoking "paradox"
-
Motovska Z, Widimsky P, Petr R, Bilkova D, Marinov I, Simek S, et al. Factors influencing clopidogrel efficacy in patients with stable coronary artery disease undergoing elective percutaneous coronary intervention: statin's advantage and the smoking "paradox". J Cardiovasc Pharmacol. 2009;53:368-72.
-
(2009)
J Cardiovasc Pharmacol.
, vol.53
, pp. 368-372
-
-
Motovska, Z.1
Widimsky, P.2
Petr, R.3
Bilkova, D.4
Marinov, I.5
Simek, S.6
-
14
-
-
76449094672
-
Slow response to clopidogrel predicts low response
-
Bellemain-Appaix A, Montalescot G, Silvain J, Barthélémy O, Beygui F, Collet JP, et al. Slow response to clopidogrel predicts low response. J Am Coll Cardiol. 2010;55:815-22.
-
(2010)
J Am Coll Cardiol.
, vol.55
, pp. 815-822
-
-
Bellemain-Appaix, A.1
Montalescot, G.2
Silvain, J.3
Barthélémy, O.4
Beygui, F.5
Collet, J.P.6
-
15
-
-
77957172636
-
Smoking at least 10 cigarettes per day increases platelet inhibition by clopidogrel in patients with ST-segment-elevation myocardial infarction
-
Jeong YH, Cho JH, Kang MK, Koh JS, Kim IS, Park Y, et al. Smoking at least 10 cigarettes per day increases platelet inhibition by clopidogrel in patients with ST-segment-elevation myocardial infarction. Thromb Res. 2010;126:e334-8.
-
(2010)
Thromb Res.
, vol.126
-
-
Jeong, Y.H.1
Cho, J.H.2
Kang, M.K.3
Koh, J.S.4
Kim, I.S.5
Park, Y.6
-
16
-
-
84876807915
-
Impact of smoking-cessation on platelet inhibition of clopidogrel in patients undergoing elective coronary drug-eluting stent implantation short term smoking cessation
-
(GWICC abstract)
-
Liu X, Zhou Y, Yang Q. Impact of smoking-cessation on platelet inhibition of clopidogrel in patients undergoing elective coronary drug-eluting stent implantation short term smoking cessation. Heart. 2010;96:(GWICC abstract).
-
(2010)
Heart.
, vol.96
-
-
Liu, X.1
Zhou, Y.2
Yang, Q.3
-
17
-
-
79960189314
-
The effect of ticagrelor vs clopidogrel on high on-treatment platelet reactivity: Combined analysis of the ONSET/OFFSET and RESPOND studies
-
Bliden KP, Tantry US, Storey RF, Jeong YH, Gesheff M, Wei C, et al. The effect of ticagrelor vs clopidogrel on high on-treatment platelet reactivity: combined analysis of the ONSET/OFFSET and RESPOND studies. Am Heart J. 2011;162:160-5.
-
(2011)
Am Heart J.
, vol.162
, pp. 160-165
-
-
Bliden, K.P.1
Tantry, U.S.2
Storey, R.F.3
Jeong, Y.H.4
Gesheff, M.5
Wei, C.6
-
18
-
-
79952192512
-
Enhanced clopidogrel responsiveness in smokers: Smokers' paradox is dependent on cytochrome P450 CYP1A2 status
-
Park KW, Park JJ, Jeon KH, Kang SH, Oh IY, Yang HM, et al. Enhanced clopidogrel responsiveness in smokers: smokers' paradox is dependent on cytochrome P450 CYP1A2 status. Arterioscl Thromb Vasc Biol. 2011;31:665-71.
-
(2011)
Arterioscl Thromb Vasc Biol.
, vol.31
, pp. 665-671
-
-
Park, K.W.1
Park, J.J.2
Jeon, K.H.3
Kang, S.H.4
Oh, I.Y.5
Yang, H.M.6
-
19
-
-
54949144309
-
Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation
-
Zanger UM, Turpeinen M, Klein K, Schwab M. Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation. Anal Bioanal Chem. 2008;392:1093-108.
-
(2008)
Anal Bioanal Chem.
, vol.392
, pp. 1093-1108
-
-
Zanger, U.M.1
Turpeinen, M.2
Klein, K.3
Schwab, M.4
-
20
-
-
84862504147
-
Clopidogrel efficacy and cigarette smoking status
-
Gurbel PA, Nolin T. Clopidogrel efficacy and cigarette smoking status. JAMA. 2012;307:2495-6.
-
(2012)
JAMA.
, vol.307
, pp. 2495-2496
-
-
Gurbel, P.A.1
Nolin, T.2
-
21
-
-
33748937559
-
Smoking influences the effectiveness of dual antiplatelet therapy on long-term outcomes following PCI
-
(Abstract 2920-122)
-
Saraff K. Smoking influences the effectiveness of dual antiplatelet therapy on long-term outcomes following PCI. J Am Coll Cardiol. 2006:36B:(Abstract 2920-122).
-
(2006)
J Am Coll Cardiol.
, vol.36
-
-
Saraff, K.1
-
22
-
-
73449139419
-
Smoking, clopidogrel, and mortality in patients with established cardiovascular disease
-
Berger JS, Bhatt DL, Steinhubl SR, Shao M, Steg PG, Montalescot G, et al. Smoking, clopidogrel, and mortality in patients with established cardiovascular disease. Circulation. 2009;120:2337-44.
-
(2009)
Circulation.
, vol.120
, pp. 2337-2344
-
-
Berger, J.S.1
Bhatt, D.L.2
Steinhubl, S.R.3
Shao, M.4
Steg, P.G.5
Montalescot, G.6
-
23
-
-
63549115843
-
Interaction between cigarette smoking and clinical benefit of clopidogrel
-
Desai NR, Mega JL, Jiang S, Cannon CP, Sabatine MS. Interaction between cigarette smoking and clinical benefit of clopidogrel. J Am Coll Cardiol. 2009;53:1273-8.
-
(2009)
J Am Coll Cardiol.
, vol.53
, pp. 1273-1278
-
-
Desai, N.R.1
Mega, J.L.2
Jiang, S.3
Cannon, C.P.4
Sabatine, M.S.5
-
24
-
-
77956614384
-
Smoker's paradox" and reperfusion's strategy in acute myocardial infarction
-
Addad F, Dridi Z, Jemmali M, Mzoughi K, Hassine M, Ghrissi I, et al. ["Smoker's paradox" and reperfusion's strategy in acute myocardial infarction]. Ann Cardiol Angéiol. 2010;59:183-9.
-
(2010)
Ann Cardiol Angéiol.
, vol.59
, pp. 183-189
-
-
Addad, F.1
Dridi, Z.2
Jemmali, M.3
Mzoughi, K.4
Hassine, M.5
Ghrissi, I.6
-
25
-
-
84862493269
-
Relationship between clopidogrel and cigarette smoking status in patients with acute coronary syndromes without ST-segment elevation myocardial infarction. Abstract 8
-
Salek F. Relationship between clopidogrel and cigarette smoking status in patients with acute coronary syndromes without ST-segment elevation myocardial infarction. Abstract 8. Pharmacotherapy. 2010;30:154e.
-
(2010)
Pharmacotherapy.
, vol.30
-
-
Salek, F.1
-
26
-
-
77958005516
-
Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): A randomised factorial trial
-
Mehta SR, Tanguay JF, Eikelboom JW, Jolly SS, Joyner CD, Granger CB, et al. Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial. Lancet. 2010;376:1233-43.
-
(2010)
Lancet.
, vol.376
, pp. 1233-1243
-
-
Mehta, S.R.1
Tanguay, J.F.2
Eikelboom, J.W.3
Jolly, S.S.4
Joyner, C.D.5
Granger, C.B.6
-
27
-
-
79955590331
-
Impact of smoking on acute phase outcomes of myocardial infarction
-
Wakabayashi K, Romaguera R, Laynez-Carnicero A, Maluenda G, Ben-Dor I, Sardi G, et al. Impact of smoking on acute phase outcomes of myocardial infarction. Coron Artery Dis. 2011;22:217-22.
-
(2011)
Coron Artery Dis.
, vol.22
, pp. 217-222
-
-
Wakabayashi, K.1
Romaguera, R.2
Laynez-Carnicero, A.3
Maluenda, G.4
Ben-Dor, I.5
Sardi, G.6
-
28
-
-
80052292634
-
Impact of smoking on antiplatelet effect of clopidogrel and prasugrel after loading dose and on maintenance therapy
-
Hochholzer W, Trenk D, Mega JL, Morath T, Stratz C, Valina CM, et al. Impact of smoking on antiplatelet effect of clopidogrel and prasugrel after loading dose and on maintenance therapy. Am Heart J. 2011;162:518-26.e5.
-
(2011)
Am Heart J.
, vol.162
, pp. 518-526
-
-
Hochholzer, W.1
Trenk, D.2
Mega, J.L.3
Morath, T.4
Stratz, C.5
Valina, C.M.6
-
29
-
-
23644443846
-
Impact of smoking status on outcomes of primary coronary intervention for acute myocardial infarction - The smoker's paradox revisited
-
DOI 10.1016/j.ahj.2004.01.032, PII S0002870304006234
-
Weisz G, Cox DA, Garcia E, Tcheng JE, Griffin JJ, Guagliumi G, et al. Impact of smoking status on outcomes of primary coronary intervention for acute myocardial infarction-the smoker's paradox revisited. Am Heart J. 2005;150:358-64. (Pubitemid 41116264)
-
(2005)
American Heart Journal
, vol.150
, Issue.2
, pp. 358-364
-
-
Weisz, G.1
Cox, D.A.2
Garcia, E.3
Tcheng, J.E.4
Griffin, J.J.5
Guagliumi, G.6
Stuckey, T.D.7
Rutherford, B.D.8
Mehran, R.9
Aymong, E.10
Lansky, A.11
Grines, C.L.12
Stone, G.W.13
-
30
-
-
0015890897
-
An acute effect of cigarette smoking on platelet function. A possible link between smoking and arterial thrombosis
-
Levine PH. An acute effect of cigarette smoking on platelet function. A possible link between smoking and arterial thrombosis. Circulation. 1973;48:619-23.
-
(1973)
Circulation.
, vol.48
, pp. 619-623
-
-
Levine, P.H.1
-
31
-
-
0028828489
-
Cigarette smoking acutely increases platelet thrombus formation in patients with coronary artery disease taking aspirin
-
Hung J, Lam JY, Lacoste L, Letchacovski G. Cigarette smoking acutely increases platelet thrombus formation in patients with coronary artery disease taking aspirin. Circulation. 1995;92:2432-6.
-
(1995)
Circulation.
, vol.92
, pp. 2432-2436
-
-
Hung, J.1
Lam, J.Y.2
Lacoste, L.3
Letchacovski, G.4
-
32
-
-
0033596924
-
Endothelial dysfunction, impaired endogenous fibrinolysis, and cigarette smoking: A mechanism for arterial thrombosis and myocardial infarction
-
Newby DE, Wright RA, Labinjoh C, Ludlam CA, Fox KA, Boon NA, et al. Endothelial dysfunction, impaired endogenous fibrinolysis, and cigarette smoking: a mechanism for arterial thrombosis and myocardial infarction. Circulation. 1999;99:1411-5. (Pubitemid 29140904)
-
(1999)
Circulation
, vol.99
, Issue.11
, pp. 1411-1415
-
-
Newby, D.E.1
Wright, R.A.2
Labinjoh, C.3
Ludlam, C.A.4
Fox, K.A.A.5
Boon, N.A.6
Webb, D.J.7
-
33
-
-
0014315640
-
Prognosis of men after first myocardial infarction: Mortality and first recurrence in relation to selected parameters
-
Weinblatt E, Shapiro S, Frank CW, Sager RV. Prognosis of men after first myocardial infarction: mortality and first recurrence in relation to selected parameters. Am J Pub Health Nation's Health. 1968;58:1329-47.
-
(1968)
Am J Pub Health Nation's Health.
, vol.58
, pp. 1329-1347
-
-
Weinblatt, E.1
Shapiro, S.2
Frank, C.W.3
Sager, R.V.4
-
34
-
-
0015782977
-
Short and long-term prognostic indices in acute myocardial infarction. A study of 606 patients initially treated in a coronary care unit
-
Helmers C. Short and long-term prognostic indices in acute myocardial infarction. A study of 606 patients initially treated in a coronary care unit. Acta Med Scand. Suppl 1973;555:7-26.
-
(1973)
Acta Med Scand. Suppl
, vol.555
, pp. 7-26
-
-
Helmers, C.1
-
35
-
-
0022189646
-
Smoking status at the time of acute myocardial infarction and subsequent prognosis
-
DOI 10.1016/0002-8703(85)90071-7
-
Kelly TL, Gilpin E, Ahnve S, Henning H, Ross J. Smoking status at the time of acute myocardial infarction and subsequent prognosis. Am Heart J. 1985;110:535-41. (Pubitemid 16031168)
-
(1985)
American Heart Journal
, vol.110
, Issue.3
, pp. 535-541
-
-
Kelly, T.L.1
Gilpin, E.2
Ahnve, S.3
-
36
-
-
0035859945
-
Impact of smoking on clinical and angiographic restenosis after percutaneous coronary intervention: Another smoker's paradox?
-
Cohen DJ, Doucet M, Cutlip DE, Ho KK, Popma JJ, Kuntz RE. Impact of smoking on clinical and angiographic restenosis after percutaneous coronary intervention: another smoker's paradox? Circulation. 2001;104:773-8. (Pubitemid 32762674)
-
(2001)
Circulation
, vol.104
, Issue.7
, pp. 773-778
-
-
Cohen, D.J.1
Doucet, M.2
Cutlip, D.E.3
Ho, K.K.L.4
Popma, J.J.5
Kuntz, R.E.6
-
37
-
-
0031049589
-
Effect of smoking status on the long-term outcome after successful percutaneous coronary revascularization
-
DOI 10.1056/NEJM199703133361103
-
Hasdai D, Garratt KN, Grill DE, Lerman A, Holmes DR. Effect of smoking status on the long-term outcome after successful percutaneous coronary revascularization. N Engl J Med. 1997;336:755-61. (Pubitemid 27113969)
-
(1997)
New England Journal of Medicine
, vol.336
, Issue.11
, pp. 755-761
-
-
Hasdai, D.1
Garratt, K.N.2
Grill, D.E.3
Lerman, A.4
Holmes Jr., D.R.5
-
38
-
-
0028962712
-
Acute myocardial infarction in the young-The role of smoking. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial
-
Barbash GI, White HD, Modan M, Diaz R, Hampton JR, Heikkila J, et al. Acute myocardial infarction in the young-the role of smoking. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. Eur Heart J. 1995;16:313-6.
-
(1995)
Eur Heart J.
, vol.16
, pp. 313-316
-
-
Barbash, G.I.1
White, H.D.2
Modan, M.3
Diaz, R.4
Hampton, J.R.5
Heikkila, J.6
-
39
-
-
80052035934
-
The "smoker's paradox" in patients with acute coronary syndrome: A systematic review
-
Aune E, Røislien J, Mathisen M, Thelle DS, Otterstad JE. The "smoker's paradox" in patients with acute coronary syndrome: a systematic review. BMC Med. 2011;9:97.
-
(2011)
BMC Med.
, vol.9
, pp. 97
-
-
Aune, E.1
Røislien, J.2
Mathisen, M.3
Thelle, D.S.4
Otterstad, J.E.5
-
40
-
-
33845249719
-
Nicotine upregulates the expression of P2Y12 on vascular cells and megakaryoblasts
-
DOI 10.1007/s11239-006-9033-4
-
Shanker G, Kontos JL, EckmanDM, Wesley-FarringtonD, SaneDC. Nicotine upregulates the expression of P2Y12 on vascular cells and megakaryoblasts. J Thromb Thrombolysis. 2006;22:213-20. (Pubitemid 44857783)
-
(2006)
Journal of Thrombosis and Thrombolysis
, vol.22
, Issue.3
, pp. 213-220
-
-
Shanker, G.1
Kontos, J.L.2
Eckman, D.M.3
Wesley-Farrington, D.4
Sane, D.C.5
-
41
-
-
0033973850
-
Platelet aggregation induced by ADP or epinephrine is enhanced in habitual smokers
-
DOI 10.1016/S0049-3848(99)00137-1, PII S0049384899001371
-
Fusegawa Y, Handa S. Platelet aggregation induced by ADP or epinephrine is enhanced in habitual smokers. Thromb Res. 2000;97:287-95. (Pubitemid 30089033)
-
(2000)
Thrombosis Research
, vol.97
, Issue.5
, pp. 287-295
-
-
Fusegawa, Y.1
Handa, S.2
-
42
-
-
77449149717
-
Platelet adenosine diphosphate P2Y12 receptor antagonism: Benefits and limitations of current treatment strategies and future directions
-
Angiolillo DJ, Ferreiro JL. Platelet adenosine diphosphate P2Y12 receptor antagonism: benefits and limitations of current treatment strategies and future directions. Rev Esp Cardiol. 2010;63:60-76.
-
(2010)
Rev Esp Cardiol.
, vol.63
, pp. 60-76
-
-
Angiolillo, D.J.1
Ferreiro, J.L.2
-
43
-
-
36348943475
-
Common polymorphisms of CYP2C19 and CYP2C9 affect the pharmacokinetic and pharmacodynamic response to clopidogrel but not prasugrel
-
DOI 10.1111/j.1538-7836.2007.02775.x
-
Brandt JT, Close SL, Iturria SJ, Payne CD, Farid NA, Ernest CS 2nd, et al. Common polymorphisms of CYP2C19 and CYP2C9 affect the pharmacokinetic and pharmacodynamic response to clopidogrel but not prasugrel. J Thromb Haemost JTH. 2007;5:2429-36. (Pubitemid 350154353)
-
(2007)
Journal of Thrombosis and Haemostasis
, vol.5
, Issue.12
, pp. 2429-2436
-
-
Brandt, J.T.1
Close, S.L.2
Iturria, S.J.3
Payne, C.D.4
Farid, N.A.5
Ernest, C.S.6
Lachno, D.R.7
Salazar, D.8
Winters, K.J.9
-
44
-
-
80053289254
-
The evolution of antiplatelet therapy in cardiovascular disease
-
Yousuf O, Bhatt DL. The evolution of antiplatelet therapy in cardiovascular disease. Nat Rev Cardiol. 2011;8:547-59.
-
(2011)
Nat Rev Cardiol.
, vol.8
, pp. 547-559
-
-
Yousuf, O.1
Bhatt, D.L.2
-
45
-
-
0034691260
-
Early potent antithrombotic effect with combined aspirin and a loading dose of clopidogrel on experimental arterial thrombogenesis in humans
-
Cadroy Y, Bossavy JP, Thalamas C, Sagnard L, Sakariassen K, Boneu B. Early potent antithrombotic effect with combined aspirin and a loading dose of clopidogrel on experimental arterial thrombogenesis in humans. Circulation. 2000;101:2823-8. (Pubitemid 30396013)
-
(2000)
Circulation
, vol.101
, Issue.24
, pp. 2823-2828
-
-
Cadroy, Y.1
Bossavy, J.-P.2
Thalamas, C.3
Sagnard, L.4
Sakariassen, K.5
Boneu, B.6
-
46
-
-
0033866804
-
Antiplatelet effects of clopidogrel compared with aspirin after myocardial infarction: Enhanced inhibitory effects of combination therapy
-
Moshfegh K, Redondo M, Julmy F, Wuillemin WA, Gebauer MU, Haeberli A, et al. Antiplatelet effects of clopidogrel compared with aspirin after myocardial infarction: enhanced inhibitory effects of combination therapy. J Am Coll Cardiol. 2000;36:699-705.
-
(2000)
J Am Coll Cardiol.
, vol.36
, pp. 699-705
-
-
Moshfegh, K.1
Redondo, M.2
Julmy, F.3
Wuillemin, W.A.4
Gebauer, M.U.5
Haeberli, A.6
-
47
-
-
0035252921
-
Comparison of effects of clopidogrel versus ticlopidine on platelet function in patients undergoing coronary stent placement
-
DOI 10.1016/S0002-9149(00)01369-2, PII S0002914900013692
-
Gawaz M, Seyfarth M, Muller I, Rudiger S, Pogatsa-Murray G, Wolf B, et al. Comparison of effects of clopidogrel versus ticlopidine on platelet function in patients undergoing coronary stent placement. Am J Cardiol. 2001;87:332-6. A9. (Pubitemid 32144877)
-
(2001)
American Journal of Cardiology
, vol.87
, Issue.3
, pp. 332-336
-
-
Gawaz, M.1
Seyfarth, M.2
Muller, I.3
Rudiger, S.4
Pogatsa-Murray, G.5
Wolf, B.6
Schomig, A.7
-
48
-
-
70350025236
-
CYP2C19*2 polymorphism is not the sole determinant of the response to clopidogrel: Implications for its monitoring
-
Aleil B, Léon C, Cazenave J-P, Gachet C. CYP2C19*2 polymorphism is not the sole determinant of the response to clopidogrel: implications for its monitoring. J Thromb Haemost JTH. 2009;7:1747-9.
-
(2009)
J Thromb Haemost JTH.
, vol.7
, pp. 1747-1749
-
-
Aleil, B.1
Léon, C.2
Cazenave, J.-P.3
Gachet, C.4
-
49
-
-
1642453779
-
Contribution of Hepatic Cytochrome P450 3A4 Metabolic Activity to the Phenomenon of Clopidogrel Resistance
-
DOI 10.1161/01.CIR.0000112378.09325.F9
-
Lau WC, Gurbel PA, Watkins PB, Neer CJ, Hopp AS, Carville DG, et al. Contribution of hepatic cytochrome P450 3A4 metabolic activity to the phenomenon of clopidogrel resistance. Circulation. 2004;109:166-71. (Pubitemid 38114134)
-
(2004)
Circulation
, vol.109
, Issue.2
, pp. 166-171
-
-
Lau, W.C.1
Gurbel, P.A.2
Watkins, P.B.3
Neer, C.J.4
Hopp, A.S.5
Carville, D.G.M.6
Guyer, K.E.7
Tait, A.R.8
Bates, E.R.9
-
50
-
-
0038508970
-
The metabolism of clopidogrel is catalyzed by human cytochrome P450 3A and is inhibited by atorvastatin
-
DOI 10.1124/dmd.31.1.53
-
Clarke TA, Waskell LA. The metabolism of clopidogrel is catalyzed by human cytochrome P450 3A and is inhibited by atorvastatin. Drug Metab Dispos. 2003;31:53-9. (Pubitemid 36735258)
-
(2003)
Drug Metabolism and Disposition
, vol.31
, Issue.1
, pp. 53-59
-
-
Clarke, T.A.1
Waskell, L.A.2
-
51
-
-
58749094444
-
Cytochrome p-450 polymorphisms and response to clopidogrel
-
Mega JL, Close SL, Wiviott SD, Shen L, Hockett RD, Brandt JT, et al. Cytochrome p-450 polymorphisms and response to clopidogrel. N Engl J Med. 2009;360:354-62.
-
(2009)
N Engl J Med.
, vol.360
, pp. 354-362
-
-
Mega, J.L.1
Close, S.L.2
Wiviott, S.D.3
Shen, L.4
Hockett, R.D.5
Brandt, J.T.6
-
52
-
-
69249219296
-
Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy
-
Shuldiner A, O'Connell J. Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy. JAMA. 2009;302:849-57.
-
(2009)
JAMA.
, vol.302
, pp. 849-857
-
-
Shuldiner, A.1
O'Connell, J.2
-
53
-
-
33749339075
-
Cytochrome P450 2C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjects
-
DOI 10.1182/blood-2006-04-013052
-
Hulot JS, Bura A, Villard E, Azizi M, Remones V, Goyenvalle C, et al. Cytochrome P450 2C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjects. Blood. 2006;108:2244-7. (Pubitemid 44497506)
-
(2006)
Blood
, vol.108
, Issue.7
, pp. 2244-2247
-
-
Hulot, J.-S.1
Bura, A.2
Villard, E.3
Azizi, M.4
Remones, V.5
Goyenvalle, C.6
Aiach, M.7
Lechat, P.8
Gaussem, P.9
-
54
-
-
43049179414
-
Cytochrome P450 2C19 681G>A Polymorphism and High On-Clopidogrel Platelet Reactivity Associated With Adverse 1-Year Clinical Outcome of Elective Percutaneous Coronary Intervention With Drug-Eluting or Bare-Metal Stents
-
DOI 10.1016/j.jacc.2007.12.056, PII S0735109708008656
-
Trenk D, Hochholzer W, Fromm MF, Chialda LE, Pahl A, Valina CM, et al. Cytochrome P450 2C19 681 G>A polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stents. J Am Coll Cardiol. 2008;51:1925-34. (Pubitemid 351636443)
-
(2008)
Journal of the American College of Cardiology
, vol.51
, Issue.20
, pp. 1925-1934
-
-
Trenk, D.1
Hochholzer, W.2
Fromm, M.F.3
Chialda, L.-E.4
Pahl, A.5
Valina, C.M.6
Stratz, C.7
Schmiebusch, P.8
Bestehorn, H.-P.9
Buttner, H.J.10
Neumann, F.-J.11
-
55
-
-
58249135635
-
Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: A cohort study
-
Collet JP, Hulot JS, Pena A, Villard E, Esteve JB, Silvain J, et al. Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study. Lancet. 2009;373:309-17.
-
(2009)
Lancet.
, vol.373
, pp. 309-317
-
-
Collet, J.P.1
Hulot, J.S.2
Pena, A.3
Villard, E.4
Esteve, J.B.5
Silvain, J.6
-
56
-
-
0032840453
-
Dose-dependent up-regulation of rat pulmonary, renal, and hepatic cytochrome P-450 (CYP) 1A expression by nicotine feeding
-
Iba MM, Fung J, Pak YW, Thomas PE, Fisher H, Sekowski A, et al. Dose-dependent up-regulation of rat pulmonary, renal, and hepatic cytochrome P-450 (CYP) 1A expression by nicotine feeding. Drug Metab Dispos. 1999;27:977-82. (Pubitemid 29409630)
-
(1999)
Drug Metabolism and Disposition
, vol.27
, Issue.9
, pp. 977-982
-
-
Iba, M.M.1
Fung, J.2
Pak, Y.W.3
Thomas, P.E.4
Fisher, H.5
Sekowski, A.6
Halladay, A.K.7
Wagner, G.C.8
-
57
-
-
0035325768
-
Induction of CYP1A by benzo[k]fluoranthene in human hepatocytes: CYP1A1 or CYP1A2?
-
DOI 10.1006/abbi.2001.2323
-
Liu N, Zhang Q, Vakharia D, Dunbar D, Kaminsky LS. Induction of CYP1A by benzo fluoranthene in human hepatocytes: CYP1A1 or CYP1A2? Arch Biochem. 2001;389:130-4. (Pubitemid 32911550)
-
(2001)
Archives of Biochemistry and Biophysics
, vol.389
, Issue.1
, pp. 130-134
-
-
Liu, N.1
Zhang, Q.-Y.2
Vakharia, D.3
Dunbar, D.4
Kaminsky, L.S.5
-
58
-
-
0036667961
-
The interindividual differences in the 3-demthylation of caffeine alias CYP1A2 is determined by both genetic and environmental factors
-
DOI 10.1097/00008571-200208000-00008
-
Rasmussen BB, Brix TH, Kyvik KO, Brøsen K. The interindividual differences in the 3-demthylation of caffeine alias CYP1A2 is determined by both genetic and environmental factors. Pharmacogenetics. 2002;12:473-8. (Pubitemid 34913530)
-
(2002)
Pharmacogenetics
, vol.12
, Issue.6
, pp. 473-478
-
-
Rasmussen, B.B.1
Brix, T.H.2
Kyvik, K.O.3
Brosen, K.4
-
59
-
-
77951447009
-
Structure, function, regulation, and polymorphism and the clinical significance of human cytochrome P450 1A2
-
Zhou S-F, Wang B, Yang L-P, Liu J-P. Structure, function, regulation, and polymorphism and the clinical significance of human cytochrome P450 1A2. Drug Metab Rev. 2010;42:268-354.
-
(2010)
Drug Metab Rev.
, vol.42
, pp. 268-354
-
-
Zhou, S.-F.1
Wang, B.2
Yang, L.-P.3
Liu, J.-P.4
-
60
-
-
34247609838
-
Comparisons of CYP1A2 genetic polymorphisms, enzyme activity and the genotype-phenotype relationship in Swedes and Koreans
-
DOI 10.1007/s00228-007-0288-2
-
Ghotbi R, Christensen M, Roh HK, Ingelman-Sundberg M, Aklillu E, Bertilsson L. Comparisons of CYP1A2 genetic polymorphisms, enzyme activity, and the genotype-phenotype relationship in Swedes and Koreans. Eur J Clin Pharmacol. 2007;63:537-46. (Pubitemid 46684487)
-
(2007)
European Journal of Clinical Pharmacology
, vol.63
, Issue.6
, pp. 537-546
-
-
Ghotbi, R.1
Christensen, M.2
Roh, H.-K.3
Ingelman-Sundberg, M.4
Aklillu, E.5
Bertilsson, L.6
-
61
-
-
0032908778
-
Functional significance of a C→A polymorphism in intron I of the cytochrome P450 CYP1A2 gene tested with caffeine
-
DOI 10.1046/j.1365-2125.1999.00898.x
-
Sachse C, Brockmöller J, Bauer S, Roots I. Functional significance of a C->A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine. Br J Clin Pharmacol. 1999;47:445-9. (Pubitemid 29161279)
-
(1999)
British Journal of Clinical Pharmacology
, vol.47
, Issue.4
, pp. 445-449
-
-
Sachse, C.1
Brockmoller, J.2
Bauer, S.3
Roots, I.4
-
63
-
-
0035719054
-
A randomized open trial for comparison of proton pump inhibitors, omeprazole versus rabeprazole, in dual therapy for Helicobacter pylori infection in relation to CYP2C19 genetic polymorphism
-
DOI 10.1046/j.1440-1746.2001.02526.x
-
Miyoshi M, Mizuno M. Comparison of proton pump inhibitors, omeprazole vs rabeprazole, in dual therapy for Helicobacter pylori infection in relation to CYP2C19 genetic polymorphism. J Gastroenterol Hepatol. 2001;723-8. (Pubitemid 34188807)
-
(2001)
Journal of Gastroenterology and Hepatology
, vol.16
, Issue.7
, pp. 723-728
-
-
Miyoshi, M.1
Mizuno, M.2
Ishiki, K.3
Nagahara, Y.4
Maga, T.5
Torigoe, T.6
Nasu, J.7
Okada, H.8
Yokota, K.9
Oguma, K.10
Tsuji, T.11
-
64
-
-
78650720489
-
Cigarette smoke extract induces CYP2B6 through constitutive androstane receptor in hepatocytes
-
Washio I, Maeda M, Sugiura C, Shiga R, Yoshida M, Nonen S, et al. Cigarette smoke extract induces CYP2B6 through constitutive androstane receptor in hepatocytes. DrugMetab Dispos. 2011;39:1-3.
-
(2011)
DrugMetab Dispos.
, vol.39
, pp. 1-3
-
-
Washio, I.1
Maeda, M.2
Sugiura, C.3
Shiga, R.4
Yoshida, M.5
Nonen, S.6
-
65
-
-
0037308012
-
Regulation of CYP3A5 by glucocorticoids and cigarette smoke in human lung-derived cells
-
DOI 10.1124/jpet.102.038208
-
Hukkanen J, Väisänen T, Lassila A, Piipari R, Anttila S, Pelkonen O, et al. Regulation of CYP3A5 by glucocorticoids and cigarette smoke in human lung-derived cells. Am Soc Pharmacol Exp Ther. 2003;304:745-52. (Pubitemid 36152353)
-
(2003)
Journal of Pharmacology and Experimental Therapeutics
, vol.304
, Issue.2
, pp. 745-752
-
-
Hukkanen, J.1
Vaisanen, T.2
Lassila, A.3
Piipari, R.4
Anttila, S.5
Pelkonen, O.6
Raunio, H.7
Hakkola, J.8
-
66
-
-
84858754393
-
Cigarette smoking is associated with a doseresponse effect in clopidogrel-treated patients with diabetes mellitus and coronary artery disease. Results of a pharmacodynamic study
-
Ueno M, Ferreiro JL, Desai B, Tomasello SD, Tello-Montoliu A, Capodanno D, et al. Cigarette smoking is associated with a doseresponse effect in clopidogrel-treated patients with diabetes mellitus and coronary artery disease. Results of a pharmacodynamic study. JACC. 2012;5:293-300.
-
(2012)
JACC.
, vol.5
, pp. 293-300
-
-
Ueno, M.1
Ferreiro, J.L.2
Desai, B.3
Tomasello, S.D.4
Tello-Montoliu, A.5
Capodanno, D.6
-
67
-
-
77950983043
-
The impact of smoking on post-clopidogrel platelet reactivity in patients with acute myocardial infarction
-
Cho JH, Jeong YH, Ahn YJ, Kang MK, Koh JS, Kim IS, et al. The impact of smoking on post-clopidogrel platelet reactivity in patients with acute myocardial infarction. Korean Circ J. 2010;40:119-24.
-
(2010)
Korean Circ J.
, vol.40
, pp. 119-124
-
-
Cho, J.H.1
Jeong, Y.H.2
Ahn, Y.J.3
Kang, M.K.4
Koh, J.S.5
Kim, I.S.6
-
68
-
-
37549006004
-
The Residual Platelet Aggregation after Deployment of Intracoronary Stent (PREDICT) score
-
Geisler T, Grass D, Bigalke B, Stellos K, Drosch T, DietzK, et al. The Residual Platelet Aggregation after Deployment of Intracoronary Stent (PREDICT) score. J Thrombd Haemost JTH. 2008;6:54-61.
-
(2008)
J Thrombd Haemost JTH.
, vol.6
, pp. 54-61
-
-
Geisler, T.1
Grass, D.2
Bigalke, B.3
Stellos, K.4
Dietzk, D.T.5
-
69
-
-
78649373563
-
Association between smoking, outcomes, and early clopidogrel use in patients with acute coronary syndrome: Insights from the Global Registry of Acute Coronary Events
-
Sibbald M, Yan AT, Huang W, Fox KA, Gore JM, Steg PG, et al. Association between smoking, outcomes, and early clopidogrel use in patients with acute coronary syndrome: insights from the Global Registry of Acute Coronary Events. Am Heart J. 2010;160:855-61.
-
(2010)
Am Heart J.
, vol.160
, pp. 855-861
-
-
Sibbald, M.1
Yan, A.T.2
Huang, W.3
Fox, K.A.4
Gore, J.M.5
Steg, P.G.6
-
70
-
-
68249144596
-
The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: A TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel- Thrombolysis in Myocardial Infarction 38) analysis
-
O'Donoghue M, Antman EM, Braunwald E, Murphy SA, Steg PG, Finkelstein A, et al. The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel- Thrombolysis In Myocardial Infarction 38) analysis. J Am Coll Cardiol. 2009;54:678-85.
-
(2009)
J Am Coll Cardiol.
, vol.54
, pp. 678-685
-
-
O'Donoghue, M.1
Antman, E.M.2
Braunwald, E.3
Murphy, S.A.4
Steg, P.G.5
Finkelstein, A.6
-
71
-
-
0021693142
-
Smoking following myocardial infarction: A critical review of the literature
-
Burling TA, Singleton EG, Bigelow GE, Baile WF, Gottlieb SH. Smoking following myocardial infarction: a critical review of the literature. Heal Psychol. 1984;3:83-96.
-
(1984)
Heal Psychol.
, vol.3
, pp. 83-96
-
-
Burling, T.A.1
Singleton, E.G.2
Bigelow, G.E.3
Baile, W.F.4
Gottlieb, S.H.5
-
72
-
-
3543019165
-
Time response of cytochrome P450 1A2 activity on cessation of heavy smoking
-
DOI 10.1016/j.clpt.2004.04.003, PII S0009923604001286
-
Faber MS, Fuhr U. Time response of cytochrome P450 1A2 activity on cessation of heavy smoking. Clin Pharmacol Ther. 2004;76:178-84. (Pubitemid 39013407)
-
(2004)
Clinical Pharmacology and Therapeutics
, vol.76
, Issue.2
, pp. 178-184
-
-
Faber, M.S.1
Fuhr, U.2
-
73
-
-
84862019325
-
Enhanced clopidogrel response in smokers is reversed after discontinuation as assessed by VerifyNow assay: Additional evidence for the concept of 'smokers' paradox'
-
ParkKW, Kang SH, Kang J, Jeon KH, Park JJ, Han JK, et al. Enhanced clopidogrel response in smokers is reversed after discontinuation as assessed by VerifyNow assay: additional evidence for the concept of 'smokers' paradox'. Heart. 2012;98:1000-6.
-
(2012)
Heart.
, vol.98
, pp. 1000-1006
-
-
Parkkw Kang, S.H.1
Kang, J.2
Jeon, K.H.3
Park, J.J.4
Han, J.K.5
-
74
-
-
77958105401
-
Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON-TIMI 38 trial: A pharmacogenetic analysis
-
Mega JL, Close SL, Wiviott SD, Shen L, Walker JR, Simon T, et al. Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON-TIMI 38 trial: a pharmacogenetic analysis. Lancet. 2010;376:1312-9.
-
(2010)
Lancet.
, vol.376
, pp. 1312-1319
-
-
Mega, J.L.1
Close, S.L.2
Wiviott, S.D.3
Shen, L.4
Walker, J.R.5
Simon, T.6
-
75
-
-
84895907642
-
TCT-54 the influence of smoking status on the pharmacodynamics of prasugrel and clopidogrel: The PARADOX Study
-
(Abstract)
-
Gurbel P, Bliden K, Logan D, Al. E. TCT-54 The influence of smoking status on the pharmacodynamics of prasugrel and clopidogrel: the PARADOX Study. J Am Coll Cardiol. 2012;60(17 Suppl): (Abstract).
-
(2012)
J Am Coll Cardiol.
, vol.60
, Issue.17 SUPPL.
-
-
Gurbel, P.1
Bliden, K.2
Logan, D.3
-
76
-
-
84866325657
-
Prior smoking status, clinical outcomes, and the comparison of ticagrelor with clopidogrel in acute coronary syndromes. Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial
-
e1
-
Cornel JH, Becker RC, Goodman SG, Husted S, Katus H, Santoso A, et al. Prior smoking status, clinical outcomes, and the comparison of ticagrelor with clopidogrel in acute coronary syndromes. Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial. Am Heart J. 2012;164:334-42.e1.
-
(2012)
Am Heart J.
, vol.164
, pp. 334-342
-
-
Cornel, J.H.1
Becker, R.C.2
Goodman, S.G.3
Husted, S.4
Katus, H.5
Santoso, A.6
-
77
-
-
84876798728
-
CYP1A2-inducing medications improve platelet responsiveness to clopidrogrel
-
Abstract 58
-
Gengo F, Robson M, Rainka M. CYP1A2-inducing medications improve platelet responsiveness to clopidrogrel. J Clini Pharmacol. 2010;50:1069. Abstract 58.
-
(2010)
J Clini Pharmacol.
, vol.50
, pp. 1069
-
-
Gengo, F.1
Robson, M.2
Rainka, M.3
-
78
-
-
84895906489
-
Serum cotinine levels are associated with increased clopidrogrel-induced antiplatelet effects in patients with diabetes mellitus and coronary artery disease
-
Ueno M, Ferreiro J, Dharmashankar K, Tomasselo S. Serum cotinine levels are associated with increased clopidrogrel-induced antiplatelet effects in patients with diabetes mellitus and coronary artery disease. New Orleans: American College of Cardiology (ACC); 2011.
-
New Orleans: American College of Cardiology (ACC)
, vol.2011
-
-
Ueno, M.1
Ferreiro, J.2
Dharmashankar, K.3
Tomasselo, S.4
-
79
-
-
60949083948
-
Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis
-
Sibbing D, Braun S, Morath T, Mehilli J, Vogt W, Schömig A, et al. Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis. J Am Coll Cardiol. 2009;53:849-56.
-
(2009)
J Am Coll Cardiol.
, vol.53
, pp. 849-856
-
-
Sibbing, D.1
Braun, S.2
Morath, T.3
Mehilli, J.4
Vogt, W.5
Schömig, A.6
-
80
-
-
0030590746
-
Anon. A randomized, blinded, trial of clopidogrel vs aspirin in patients at risk of ischemic events (CAPRIE)
-
CAPRIE Steering Committee
-
Anon. A randomized, blinded, trial of clopidogrel vs aspirin in patients at risk of ischemic events (CAPRIE). CAPRIE Steering Committee. Lancet. 1996;348:1329-39.
-
(1996)
Lancet.
, vol.348
, pp. 1329-1339
-
-
|